ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026
Intrinsic neutrophil dysregulation in programmed cell death promotes neutrophilic inflammation in cystic fibrosis.
Article in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efferocytosis: unifying pathogenic hub in metabolic disorders-mechanistic landscapes, targeted therapies and translational bottlenecks.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neutrophilic inflammation constitutes a major pathology in cystic fibrosis (CF), a life-shortening genetic disorder. However, the underlying mechanisms remain incompletely understood. Here we report our investigation into CF neutrophil recruitment, apoptosis and clearance to determine if any neutrophil intrinsic defect is involved in the pathogenesis. Congenic fluorescent wild-type (WT) and CF mice were generated and used as bone marrow (BM) donors. Non-fluorescent WT and CF recipients were transplanted with a mixture of EGFP-WT and DsRed-CF BM cells and interrogated for neutrophil recruitment and apoptosis in the same lung after zymosan challenge. Additionally, ex vivo neutrophil migration and apoptosis were also examined to confirm the in vivo findings. Moreover, DsRed-WT or DsRed-CF BM cells were transfused into non-fluorescent CF recipients that had been intratracheally challenged with zymosan. Percentages of apoptotic cell-laden macrophages in the lungs were compared. The data indicate that CF and WT neutrophils exhibited a similar migratory capacity and were equally recruited to the same lung, regardless of the recipient phenotype. However, CF neutrophils displayed a significantly delayed apoptosis. Such an anomaly was linked to reduced hypochlorous acid production. Moreover, CF macrophages exhibited a significantly higher expression of efferocytosis marker MerTK, and a greater capacity of efferocytosis, implying that macrophage phagocytosis of apoptotic cells is not impaired in this experimental setting. These findings suggest that intrinsically dysregulated programmed cell death affects CF neutrophil fate decision and fuels neutrophilic inflammation in CF lungs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.